Oral delivery of a chitosan adjuvanted COVID-19 vaccine provides long-lasting and broad-spectrum protection against SARS-CoV-2 variants of concern in golden hamsters-Reference-Cited by-同舟云学术

Oral delivery of a chitosan adjuvanted COVID-19 vaccine provides long-lasting and broad-spectrum protection against SARS-CoV-2 variants of concern in golden hamsters

Published:2023-12 Issue: Volume:220 Page:105765
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Wang Shen,Cui Huan,Zhang Cheng,Li Wujian,Wang Weiqi,He Wenwen,Feng Na,Zhao Yongkun,Wang Tiecheng,Tang Xiaoqing,Yan Feihu,Xia Xianzhu

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference57 articles.

1. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine;Ambrose;Vaccine,2012

2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2021

3. Localized mucosal response to intranasal live attenuated influenza vaccine in adults;Barría;J. Infect. Dis.,2013

4. Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes;Bea;Diabetes Obes. Metabol.,2023

5. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters;Bricker;Cell Rep.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases;Pharmaceutics;2024-09-13

2. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

3. Advanced biopolymeric materials and nanosystems for RNA/DNA vaccines: a review;Nanomedicine;2024-08-07

4. Prospects of Innovative Therapeutics in Combating the COVID-19 Pandemic;Molecular Biotechnology;2024-08-01

5. Fasting before Intra-Gastric Dosing with Antigen Improves Intestinal Humoral Responses in Syrian Hamsters;Vaccines;2024-05-24